- Home
- /
- Treatment
- /
- Page 32
Treatments
The following database contains products that have been granted orphan status, or have been market approval in the EU or the USA.
You can filter the content by clicking on the titles: Product, Indication, Sponsor and Date. Clicking once, will filter the column alphabetically from A – Z and a second click on the same title will filter from Z – A.
Become a Partner.
Country | Product | Indication | Sponsor | Date |
---|---|---|---|---|
Metavert, N-hydroxy-4-(5-((4-methoxyphenyl)amino)-1,3,4-oxadiazol-2-yl)benzamide | Pancreatic Cancer | Avenzoar Pharmaceuticals, Inc.;662 Encinitas Blvd, Suite 248;Encinitas, California, 92024 | July 6, 2016 | |
Anti-HER2 bispecific antibody drug conjugate | Ovarian cancer | Zymeworks Inc.;18 West Mercer Street, Suite 370;Seattle, Washington, 98119 | July 6, 2016 | |
Nintedanib | Systemic scleroderma | Boehringer Ingelheim Pharmaceuticals, Inc.;900 Ridgebury Road, Box 368;Ridgefield, Connecticut, 06877 | July 6, 2016 | |
Mazindol | Narcolepsy | NLS-0 Pharma AG;10 Breitenweg, CH-6370;Stans NW | July 6, 2016 | |
Modified mRNA encoding UGT1A1 protein, formulated in lipid nanoparticles | Crigler-Najjar syndrome | Moderna Therapeutics, Inc.;320 Bent Street;Cambridge, Massachusetts, 02141 | July 5, 2016 | |
Bortezomib | Neurofibromatosis type 2 | BioXcel Corporation;780 East Main Street, Suite 2;Branford, Connecticut, 06405 | July 5, 2016 | |
Adenovirus-associated viral vector serotype 5 containing the human pde6B gene | Retinitis pigmentosa | HORAMA, SAS;9 Rue de l'�peron;Paris | July 5, 2016 | |
Small molecule Ewing Sarcoma breakpoint region 1/Friend leukemia virus integration 1 fusion protein inhibitor | Ewing sarcoma | Tokalas, Inc.;P. O. Box 1269;Rancho Santa Fe, California, 92067 | June 30, 2016 | |
Autologous osteogenic cells cultured from adipose tissue derived stem cells embedded in extracellular matrix with demineralized bone matrix. | Congenital pseudarthrosis of the tibia | Novadip Biosciences;11 Granbonpr�;Mont-Saint-Guibert | June 30, 2016 | |
Peptide consisting of L-amino acids with the sequence H-lys-glu-phe-leu-his-pro-ser-lys-val-asp-leu-pro-arg-OH | Pancreatic cancer | Soricimed Biopharma, Inc.;18 Botsford Street, Suite 201;Moncton, New Brunswick | June 29, 2016 | |
Recombinant, glycoenfineered humanized IgG1 kappa monoclonal antibody directed against Fibroblast Growth Factor Receptor 2b | Stomach Cancer | Five Prime Therapeutics, Inc.;2 Corporate Drive;South San Francisco, California, 94080 | June 29, 2016 | |
(S)-7-(1-acryloylpiperidin-4-yl)-2-(4-phenoxyphenyl)-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidine-3-carboxamide | Waldenstrom macroglobulinemia | BeiGene USA, Inc.;2115 Linwood Avenue, 4th Floor;Fort Lee, New Jersey, 07024 | June 29, 2016 | |
Humanised monoclonal antibody targeting interleukin-15 | Eosinophilic esophagitis Eosinophilic esophagitis | Calypso Biotech B.V. | June 27, 2016 | |
Setmelanotide | Prader-Willi syndrome | TMC Pharma Services Ltd | June 27, 2016 | |
Molgramostim | Acute respiratory distress syndrome | Savara ApS | June 27, 2016 | |
Recombinant humanised monoclonal IgG2 lambda antibody against human sclerostin | Osteogenesis imperfecta | Mereo Biopharma 3 Limited | June 27, 2016 | |
Teriparatide | Hypoparathyroidism | Alacrita LLP | June 27, 2016 | |
Triclabendazole | Fascioliasis | Tropicalis Pharmaceuticals, LLC;22345 Bracketts Road;Excelsior, Minnesota, 55331 | June 27, 2016 | |
High molecular weight multimer of E3-Fc, an endostatin C-terminus and IgG1-Fc fusion protein | Systemic scleroderma | iBio, Inc.;600 Madison Avenue, Suite 1601;New York, New York, 10022 | June 27, 2016 | |
Melatonin | Neonatal sepsis | Therapicon Srl | June 27, 2016 | |
Modified mRNA encoding the UGT1A1 protein | Crigler-Najjar syndrome | Alexion Europe SAS | June 27, 2016 | |
Recombinant protein derived from the saliva of theOrnithodoros moubatatick | Guillain-Barré syndrome | Akari Therapeutics Plc | June 27, 2016 | |
3-(5-amino-2-methyl-4-oxoquinazolin-3(4H)-yl)piperidine-2,6-dione hydrochloride | Diffuse Large B-cell Lymphoma | Celgene Europe Limited | June 27, 2016 | |
Allogeneic donor-derived ex-vivo expanded T lymphocytes transduced with a retroviral vector containing inducible caspase 9 and truncated CD19 | Treatment in haematopoietic stem cell transplantation | Bellicum Pharma Limited | June 27, 2016 | |
Citric acid monohydrate | Acute liver failure | CATS Consultants GmbH | June 27, 2016 |